Researchers at Karolinska Institutet may have found a new way to treat obesity and related disorders by targeting the cells' ...
For years, Kasia Lipska, MD, MHS, associate professor of medicine (endocrinology) at Yale School of Medicine (YSM), has been ...
The North Carolina state treasurer is taking on drugmakers Novo Nordisk and Eli Lilly in an attempt to lower drug costs for ...
GLP-1 drugs like Ozempic and Wegovy can help most people lose weight, but they don’t work for everyone. Here are 5 common ...
Drugmakers are preparing to launch an estimated 13 new weight-loss treatments in the U.S. over the next five years, according ...
Millions of Americans who have used new obesity drugs like Wegovy to lose weight and improve health are wondering what ...
which does not cover anti-obesity medications for weight-loss management. In the United States, Wegovy’s list price is US$1,350 for one month’s supply. And in the United Kingdom, where Wegovy ...
Roche Joins Race for Obesity Drugs With $2.7 Billion Carmot Deal Roche agreed to take over unlisted obesity drug developer Carmot Therapeutics for $2.7 billion upfront, joining a list of ...
“It’s not all about weight loss,” he said, adding that semaglutide ... and often linked with obesity. The growing list of potential uses for obesity drugs has been driving up expectations ...
LONDON — Following a nine-month investigation, European regulators said Friday they have found no evidence that GLP-1 drugs like Ozempic and Wegovy cause suicidal thoughts or actions. The ...
She covered several of these themes and biotechnology research as it relates to the important trend of expanding use of GLP-1 medications for weight loss and the treatment of diseases associated ...
A budget-busting 3.6 million Medicare recipients could now be eligible for coverage of the weight-loss drug Wegovy, a new KFF ...